Free Trial

Cue Biopharma (CUE) SEC Filings & 10K Form

Cue Biopharma logo
$1.61
-0.14 (-8.00%)
(As of 10/31/2024 ET)

Recent Cue Biopharma SEC Filings

DateFilerForm TypeView
10/07/2024
4:07 PM
Bleichroeder LP (Filed by)
Cue Biopharma (Subject)
Form SCHEDULE 13G/A
10/04/2024
3:00 PM
Cue Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:17 PM
Cue Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:05 PM
Cue Biopharma (Filer)
Form 424B5
09/26/2024
3:32 PM
Cue Biopharma (Filer)
Form 424B5
09/10/2024
3:00 PM
Cue Biopharma (Filer)
Form DEF 14A
09/03/2024
3:30 PM
Cue Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
3:00 PM
Cue Biopharma (Filer)
Form PRE 14A
08/16/2024
3:00 PM
Cue Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
3:00 PM
Cue Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
2:43 PM
Cue Biopharma (Filer)
Form ARS
04/26/2024
2:46 PM
Cue Biopharma (Filer)
Form DEFA14A
03/28/2024
3:29 PM
Cue Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2024
5:40 PM
Bleichroeder LP (Filed by)
Cue Biopharma (Subject)
Form SC 13G
02/07/2024
4:09 PM
BlackRock Inc. (Filed by)
Cue Biopharma (Subject)
Form SC 13G
01/31/2024
1:08 PM
BlackRock Inc. (Filed by)
Cue Biopharma (Subject)
Form SC 13G
01/04/2024
3:00 PM
Cue Biopharma (Issuer)
Morich Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:01 PM
Cue Biopharma (Issuer)
Verheyen Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:02 PM
Cue Biopharma (Issuer)
DRISCOLL FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:02 PM
Cue Biopharma (Issuer)
Kiener Peter A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:02 PM
Cue Biopharma (Issuer)
Garzone Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CUE) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners